Loading results
In the News
powered by Ovast-
Drug Maker Endo Gets Input In House Bill On Generics
nytimes.com 11 hours, 16 minutes agoA lobbying effort by Endo Pharmaceuticals led to language in a House measure requiring the F.D.A. to develop new ways of measuring the equivalence of “locally acting” generic and brand-name medicines.
-
Generics Drive Down Drug Prices In India, TPP Trying To Stop That
techdirt.com 6 days, 10 hours agoBack in March, we wrote about an important development in India, where a compulsory license for Bayer's Nexavar anti-cancer drug was granted. Bayer, of course, is fighting back : in its 37-page appeal to the Intellectual Property Appellate Board, Bayer has "demanded the withdrawal of the country’s first compulsory license given to Natco Pharma, arguing that a three-fourths reduction in the price of the anti-cancer drug by another Indian firm has made the permit redundant and its patent itself is vulnerable
Photos
powered by
Loading photos for 'Generic'
On Twitter
Loading tweets for 'Generic'
Videos
Loading videos for 'Generic'
Loading More Stories
